Journal profile · HEMATOLOGY
Journal of Clinical and Experimental Hematopathology
ISSN 1346-4280 · eISSN 1880-9952 · The Japanese Society for Lymphoreticular Tissue Research · Japan
Journal of Clinical and Experimental Hematopathology: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; APC about USD 150; review about 11 weeks (community reports); 51 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Journal of Clinical and Experimental Hematopathology is published by The Japanese Society for Lymphoreticular Tissue Research and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and Viral-associated cancers and disorders, together about 45% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): HEMATOLOGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lymphoma Diagnosis and TreatmentMedicine23.8%
- Chronic Lymphocytic Leukemia ResearchMedicine10.6%
- Viral-associated cancers and disordersMedicine10.6%
- T-cell and Retrovirus StudiesImmunology and Microbiology6.2%
- CNS Lymphoma Diagnosis and TreatmentMedicine6%
- Immune Cell Function and InteractionImmunology and Microbiology4.4%
- Histiocytic Disorders and TreatmentsMedicine3.8%
- Cutaneous lymphoproliferative disorders researchMedicine3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 2.2LetPub ·
- SJR 2026-06
- 0.51LetPub ·
- SNIP 2026-06
- 0.6LetPub ·
- h-index
- 45OpenAlex ·
- i10-index
- 220OpenAlex ·
- 2-year mean citedness
- 1.35OpenAlex ·
- Self-citation rate
- 7.1%LetPub ·
- Share of gold OA articles
- 99.2%LetPub ·
Volume
- Articles per year
- 45LetPub ·
Articles by year OpenAlex count · 1,721 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 39 | 39 | 9 |
| 2025 | 51 | 51 | 46 |
| 2024 | 46 | 46 | 128 |
| 2023 | 40 | 40 | 154 |
| 2022 | 35 | 35 | 265 |
| 2021 | 42 | 42 | 222 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 11 weeksLetPub ·
- Peer review
- Peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| LetPub | USD 150 / JPY 15,000 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- The Japanese Society for Lymphoreticular Tissue Research
- Country or region
- Japan
- Language
- English
- ISSN
- 1346-4280
- Electronic ISSN
- 1880-9952
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Journal of Clinical and Experimental Hematopathology
What CAS zone is Journal of Clinical and Experimental Hematopathology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Clinical and Experimental Hematopathology is in Zone 4 of Medicine, and in Zone 4 of the minor category Hematology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Journal of Clinical and Experimental Hematopathology?
Authors report an average review time of about 11 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Journal of Clinical and Experimental Hematopathology?
According to LetPub and DOAJ records, Journal of Clinical and Experimental Hematopathology is indexed in ESCI, Scopus and DOAJ.
Is Journal of Clinical and Experimental Hematopathology open access, and what is the APC?
Journal of Clinical and Experimental Hematopathology is a fully open-access journal. APC about USD 150.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .